首页> 外国专利> Pharmaceutical compositions containing calcium complex of (4R) -4- bis (carboxy-.kappa.O) methyl amino-.kappa.N -6,9-bis (carboxy-.kappa.O) methyl -1 - (4,4-diphenylcyclohexyl) oxy -1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-yl-acid-.kappa.N6, .kappa.N9, .kappa.011 1-oxidato (6 -), tetrahydrogen (MS-325) and its salts, and process for their preparation

Pharmaceutical compositions containing calcium complex of (4R) -4- bis (carboxy-.kappa.O) methyl amino-.kappa.N -6,9-bis (carboxy-.kappa.O) methyl -1 - (4,4-diphenylcyclohexyl) oxy -1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-yl-acid-.kappa.N6, .kappa.N9, .kappa.011 1-oxidato (6 -), tetrahydrogen (MS-325) and its salts, and process for their preparation

机译:含有[[((4R)-4-)-[双[(羧基-κO)甲基]氨基-κN] -6,9-双[(羧基-O)甲基的钙络合物的药物组合物] -1-[(4,4-二苯基环己基)氧基] -1-羟基-2-氧杂-6,9-二氮杂-1-磷杂十一烷-11-基酸-N6,N9,...。 kappa.011] 1-oxidato(6--)],四氢(MS-325)及其盐及其制备方法

摘要

The invention relates to the calcium complex of[[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.N]-6,9-bis[(carboxy-.kappa.O)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-ylic-acid-.kappa.N6,.kappa.N9,.kappa.011]1-oxidato(6-)]-, tetrahydrogen (MS-325) and its salts, pharmaceutical agents that contain these complexes for the production of agents for the reduction of effects that are caused by heavy metals as well as processes for their production.
机译:本发明涉及[[((4R)-4-] [双[(羧基-κ)O]甲基]氨基-κN] -6,9-双[(羧基-κ)的钙络合物。 )甲基] -1-[((4,4-二苯基环己基)氧基] -1-羟基-2-氧杂-6,9-二氮杂-1-膦基十一烷-11-羟基酸-N6,N9 ,.kappa.011] 1-oxidato(6-)]-,四氢(MS-325)及其盐,包含这些配合物的药剂,也用于生产减轻重金属所致影响的药剂作为生产过程。

著录项

相似文献

  • 专利
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号